CHAIN BRIDGE BANCORP INC-A (CBNA) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CBNA • US15746L1008

36.8 USD
+0.31 (+0.85%)
Last: Feb 6, 2026, 08:21 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CBNA. CBNA was compared to 381 industry peers in the Banks industry. While CBNA seems to be doing ok healthwise, there are quite some concerns on its profitability. CBNA is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • CBNA had positive earnings in the past year.
  • In the past year CBNA had a positive cash flow from operations.
CBNA Yearly Net Income VS EBIT VS OCF VS FCFCBNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

  • CBNA has a better Return On Assets (1.21%) than 76.64% of its industry peers.
  • Looking at the Return On Equity, with a value of 11.42%, CBNA is in the better half of the industry, outperforming 77.69% of the companies in the same industry.
Industry RankSector Rank
ROA 1.21%
ROE 11.42%
ROIC N/A
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)12.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBNA Yearly ROA, ROE, ROICCBNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 5 10

1.3 Margins

  • CBNA has a Profit Margin of 35.24%. This is amongst the best in the industry. CBNA outperforms 91.34% of its industry peers.
  • The Operating Margin and Gross Margin are not available for CBNA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 35.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBNA Yearly Profit, Operating, Gross MarginsCBNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • CBNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CBNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CBNA Yearly Shares OutstandingCBNA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M
CBNA Yearly Total Debt VS Total AssetsCBNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B

2.2 Solvency

  • There is no outstanding debt for CBNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC9.99%
CBNA Yearly LT Debt VS Equity VS FCFCBNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 50M 100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CBNA Yearly Current Assets VS Current LiabilitesCBNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.29%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%16.78%

3.2 Future

  • CBNA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.48% yearly.
  • The Revenue is expected to grow by 6.80% on average over the next years.
EPS Next Y30.48%
EPS Next 2Y3.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.96%
Revenue Next 2Y6.8%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CBNA Yearly Revenue VS EstimatesCBNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 20M 40M 60M
CBNA Yearly EPS VS EstimatesCBNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.95 indicates a reasonable valuation of CBNA.
  • CBNA's Price/Earnings ratio is a bit cheaper when compared to the industry. CBNA is cheaper than 64.04% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.93, CBNA is valued rather cheaply.
  • A Price/Forward Earnings ratio of 9.16 indicates a reasonable valuation of CBNA.
  • 83.73% of the companies in the same industry are more expensive than CBNA, based on the Price/Forward Earnings ratio.
  • CBNA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.77.
Industry RankSector Rank
PE 11.95
Fwd PE 9.16
CBNA Price Earnings VS Forward Price EarningsCBNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CBNA's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. CBNA is more expensive than 74.28% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.79
EV/EBITDA N/A
CBNA Per share dataCBNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y3.48%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CBNA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CHAIN BRIDGE BANCORP INC-A

NYSE:CBNA (2/6/2026, 8:21:35 PM)

36.8

+0.31 (+0.85%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-28
Earnings (Next)04-27
Inst Owners50.82%
Inst Owner Change13.89%
Ins Owners25.91%
Ins Owner Change72.39%
Market Cap241.41M
Revenue(TTM)N/A
Net Income(TTM)18.63M
Analysts80
Price Target36.38 (-1.14%)
Short Float %0.89%
Short Ratio3.55
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.72%
Min EPS beat(2)-2.86%
Max EPS beat(2)30.3%
EPS beat(4)3
Avg EPS beat(4)21.5%
Min EPS beat(4)-2.86%
Max EPS beat(4)53.38%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.87%
Min Revenue beat(2)0.96%
Max Revenue beat(2)6.78%
Revenue beat(4)4
Avg Revenue beat(4)12%
Min Revenue beat(4)0.96%
Max Revenue beat(4)25.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)12.63%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.02%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.74%
Revenue NQ rev (1m)-1.68%
Revenue NQ rev (3m)-4.52%
Revenue NY rev (1m)-1.2%
Revenue NY rev (3m)-0.94%
Valuation
Industry RankSector Rank
PE 11.95
Fwd PE 9.16
P/S 4.57
P/FCF 22.79
P/OCF 17.86
P/B 1.48
P/tB 1.48
EV/EBITDA N/A
EPS(TTM)3.08
EY8.37%
EPS(NY)4.02
Fwd EY10.92%
FCF(TTM)1.61
FCFY4.39%
OCF(TTM)2.06
OCFY5.6%
SpS8.06
BVpS24.86
TBVpS24.86
PEG (NY)0.39
PEG (5Y)N/A
Graham Number41.51
Profitability
Industry RankSector Rank
ROA 1.21%
ROE 11.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 35.24%
GM N/A
FCFM 20.03%
ROA(3y)1.01%
ROA(5y)N/A
ROE(3y)12.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 614.92%
Cap/Sales 5.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 56.85%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC9.99%
ROIC/WACCN/A
Cap/Depr(3y)39.16%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.53%
Cap/Sales(5y)N/A
Profit Quality(3y)151.13%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.29%
EPS Next Y30.48%
EPS Next 2Y3.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%16.78%
Revenue Next Year18.96%
Revenue Next 2Y6.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.13%
OCF growth 3YN/A
OCF growth 5YN/A

CHAIN BRIDGE BANCORP INC-A / CBNA FAQ

Can you provide the ChartMill fundamental rating for CHAIN BRIDGE BANCORP INC-A?

ChartMill assigns a fundamental rating of 3 / 10 to CBNA.


What is the valuation status of CHAIN BRIDGE BANCORP INC-A (CBNA) stock?

ChartMill assigns a valuation rating of 5 / 10 to CHAIN BRIDGE BANCORP INC-A (CBNA). This can be considered as Fairly Valued.


How profitable is CHAIN BRIDGE BANCORP INC-A (CBNA) stock?

CHAIN BRIDGE BANCORP INC-A (CBNA) has a profitability rating of 2 / 10.


What is the earnings growth outlook for CHAIN BRIDGE BANCORP INC-A?

The Earnings per Share (EPS) of CHAIN BRIDGE BANCORP INC-A (CBNA) is expected to grow by 30.48% in the next year.